VENETOCLAX for Plasma cell myeloma in remission: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 16 adverse event reports in the FDA FAERS database where VENETOCLAX was used for Plasma cell myeloma in remission.
Most Reported Side Effects for VENETOCLAX
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 9,412 | 17.5% | 9,399 | 774 |
| Off label use | 6,252 | 11.6% | 2,257 | 1,642 |
| Neutropenia | 3,041 | 5.7% | 626 | 1,121 |
| Febrile neutropenia | 2,663 | 5.0% | 665 | 1,725 |
| Platelet count decreased | 2,367 | 4.4% | 311 | 1,357 |
| Pyrexia | 2,351 | 4.4% | 487 | 1,834 |
| Pneumonia | 2,300 | 4.3% | 790 | 1,683 |
| Fatigue | 2,281 | 4.3% | 168 | 920 |
| Diarrhoea | 2,082 | 3.9% | 278 | 964 |
| White blood cell count decreased | 1,913 | 3.6% | 198 | 1,007 |
| Myelosuppression | 1,864 | 3.5% | 84 | 756 |
| Thrombocytopenia | 1,834 | 3.4% | 404 | 653 |
| Nausea | 1,814 | 3.4% | 197 | 772 |
| Infection | 1,757 | 3.3% | 460 | 912 |
| Anaemia | 1,671 | 3.1% | 329 | 712 |
Other Indications for VENETOCLAX
Acute myeloid leukaemia (19,774)
Chronic lymphocytic leukaemia (14,194)
Product used for unknown indication (4,628)
Myelodysplastic syndrome (2,508)
Plasma cell myeloma (1,778)
Mantle cell lymphoma (1,367)
Diffuse large b-cell lymphoma (761)
Acute myeloid leukaemia recurrent (558)
B-cell small lymphocytic lymphoma (499)
Non-hodgkin's lymphoma (485)
Other Drugs Used for Plasma cell myeloma in remission
LENALIDOMIDE (4,678)
POMALIDOMIDE (1,379)
IXAZOMIB (165)
THALIDOMIDE (62)
DEXAMETHASONE (39)
CARFILZOMIB (28)
BORTEZOMIB (22)
SELINEXOR (17)
DARATUMUMAB (9)
CYCLOPHOSPHAMIDE (8)